Real world characteristics and perceived efficacy of peginterferon beta-1a compared with other platform injectable therapies among ms patients: Evidence in five European countries

Authors
Category Primary study
JournalValue in Health
Year 2017
This article has no abstract
Epistemonikos ID: c52f47306bc18b2574dade3d721dde7c73110d0b
First added on: Feb 08, 2025